Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Perhaps HUGE, was not the right word to use. It's huge, in the sense of how Poziotinib is being perceived in the scientific community i.e. that this drug is efficacious against Exon 20 Insertion mutation so anyplace there is that mutation we should test/treat for it. I look at it this way, in any cancers that are over expressed with EGFR/HER2, they will have a proportion, like there is in NSCLC, that has the Exon 20 Insertion mutation. I don't think it's prevalent in the literature right now because it's new stuff. They didn't have tests for these mutations not that long ago. It's all recent stuff. But I'm not going to look into this too deeply until it becomes more concrete. So what do you attribute from the CC this price rise?